A case of meningoencephalomyelitis associated with immune-mediated necrotizing myopathy

[1] Allenbach Y(2020)Immune-mediated necrotizing myopathy: clinical features and pathogenesis Nat Rev Rheumatol 16 689-701

[2] Benveniste O(2018)Classification and management of adult inflammatory myopathies Lancet Neurol 17 816-828

[3] Stenzel W(2018)Autoantibodies in myositis Nat Rev Rheumatol 14 290-302

[4] Boyer O(2018)Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies JAMA Neurol 75 1528-1537

[5] Selva-O'Callaghan A(2018)224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14–16 October 2016 Neuromuscul Disord 28 87-99

[6] Pinal-Fernandez I(2012)Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome Arch Neurol 69 728-732

[7] Trallero-Araguás E(2017)Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle Arthritis Care Res (Hoboken) 69 263-270

[8] Milisenda JC(2019)In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy Ann Rheum Dis 78 131-139

[9] Grau-Junyent JM(2002)Epitope spreading in immune-mediated diseases: implications for immunotherapy Nat Rev Immunol 2 85-95

[10] Mammen AL(2021)Idiopathic inflammatory myopathies Nat Rev Dis Primers 7 86-994

[1] Allenbach Y(2020)Immune-mediated necrotizing myopathy: clinical features and pathogenesis Nat Rev Rheumatol 16 689-701

[2] Benveniste O(2018)Classification and management of adult inflammatory myopathies Lancet Neurol 17 816-828

[3] Stenzel W(2018)Autoantibodies in myositis Nat Rev Rheumatol 14 290-302

[4] Boyer O(2018)Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies JAMA Neurol 75 1528-1537

[5] Selva-O'Callaghan A(2018)224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14–16 October 2016 Neuromuscul Disord 28 87-99

[6] Pinal-Fernandez I(2012)Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome Arch Neurol 69 728-732

[7] Trallero-Araguás E(2017)Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle Arthritis Care Res (Hoboken) 69 263-270

[8] Milisenda JC(2019)In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy Ann Rheum Dis 78 131-139

[9] Grau-Junyent JM(2002)Epitope spreading in immune-mediated diseases: implications for immunotherapy Nat Rev Immunol 2 85-95

[10] Mammen AL(2021)Idiopathic inflammatory myopathies Nat Rev Dis Primers 7 86-994